Copyright Reports & Markets. All rights reserved.

Global Phenotypic Drug Discovery Market Insights, Forecast to 2028

Request for Sample of this report
Buy now

Table of Contents

    1 Report Business Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Platform
      • 1.2.3 Service
    • 1.3 Market by Application
      • 1.3.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Cancer
      • 1.3.3 Viral Infection
      • 1.3.4 Genetic Disease
      • 1.3.5 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Phenotypic Drug Discovery Market Perspective (2017-2028)
    • 2.2 Phenotypic Drug Discovery Growth Trends by Region
      • 2.2.1 Phenotypic Drug Discovery Market Size by Region: 2017 VS 2021 VS 2028
      • 2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2017-2022)
      • 2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2023-2028)
    • 2.3 Phenotypic Drug Discovery Market Dynamics
      • 2.3.1 Phenotypic Drug Discovery Industry Trends
      • 2.3.2 Phenotypic Drug Discovery Market Drivers
      • 2.3.3 Phenotypic Drug Discovery Market Challenges
      • 2.3.4 Phenotypic Drug Discovery Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Phenotypic Drug Discovery Players by Revenue
      • 3.1.1 Global Top Phenotypic Drug Discovery Players by Revenue (2017-2022)
      • 3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2017-2022)
    • 3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Players Covered: Ranking by Phenotypic Drug Discovery Revenue
    • 3.4 Global Phenotypic Drug Discovery Market Concentration Ratio
      • 3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2021
    • 3.5 Phenotypic Drug Discovery Key Players Head office and Area Served
    • 3.6 Key Players Phenotypic Drug Discovery Product Solution and Service
    • 3.7 Date of Enter into Phenotypic Drug Discovery Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Phenotypic Drug Discovery Breakdown Data by Type

    • 4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2017-2022)
    • 4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2023-2028)

    5 Phenotypic Drug Discovery Breakdown Data by Application

    • 5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2017-2022)
    • 5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Phenotypic Drug Discovery Market Size (2017-2028)
    • 6.2 North America Phenotypic Drug Discovery Market Size by Type
      • 6.2.1 North America Phenotypic Drug Discovery Market Size by Type (2017-2022)
      • 6.2.2 North America Phenotypic Drug Discovery Market Size by Type (2023-2028)
      • 6.2.3 North America Phenotypic Drug Discovery Market Share by Type (2017-2028)
    • 6.3 North America Phenotypic Drug Discovery Market Size by Application
      • 6.3.1 North America Phenotypic Drug Discovery Market Size by Application (2017-2022)
      • 6.3.2 North America Phenotypic Drug Discovery Market Size by Application (2023-2028)
      • 6.3.3 North America Phenotypic Drug Discovery Market Share by Application (2017-2028)
    • 6.4 North America Phenotypic Drug Discovery Market Size by Country
      • 6.4.1 North America Phenotypic Drug Discovery Market Size by Country (2017-2022)
      • 6.4.2 North America Phenotypic Drug Discovery Market Size by Country (2023-2028)
      • 6.4.3 United States
      • 6.4.4 Canada

    7 Europe

    • 7.1 Europe Phenotypic Drug Discovery Market Size (2017-2028)
    • 7.2 Europe Phenotypic Drug Discovery Market Size by Type
      • 7.2.1 Europe Phenotypic Drug Discovery Market Size by Type (2017-2022)
      • 7.2.2 Europe Phenotypic Drug Discovery Market Size by Type (2023-2028)
      • 7.2.3 Europe Phenotypic Drug Discovery Market Share by Type (2017-2028)
    • 7.3 Europe Phenotypic Drug Discovery Market Size by Application
      • 7.3.1 Europe Phenotypic Drug Discovery Market Size by Application (2017-2022)
      • 7.3.2 Europe Phenotypic Drug Discovery Market Size by Application (2023-2028)
      • 7.3.3 Europe Phenotypic Drug Discovery Market Share by Application (2017-2028)
    • 7.4 Europe Phenotypic Drug Discovery Market Size by Country
      • 7.4.1 Europe Phenotypic Drug Discovery Market Size by Country (2017-2022)
      • 7.4.2 Europe Phenotypic Drug Discovery Market Size by Country (2023-2028)
      • 7.4.3 Germany
      • 7.4.4 France
      • 7.4.5 U.K.
      • 7.4.6 Italy
      • 7.4.7 Russia
      • 7.4.8 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Phenotypic Drug Discovery Market Size (2017-2028)
    • 8.2 Asia-Pacific Phenotypic Drug Discovery Market Size by Type
      • 8.2.1 Asia-Pacific Phenotypic Drug Discovery Market Size by Type (2017-2022)
      • 8.2.2 Asia-Pacific Phenotypic Drug Discovery Market Size by Type (2023-2028)
      • 8.2.3 Asia-Pacific Phenotypic Drug Discovery Market Share by Type (2017-2028)
    • 8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Application
      • 8.3.1 Asia-Pacific Phenotypic Drug Discovery Market Size by Application (2017-2022)
      • 8.3.2 Asia-Pacific Phenotypic Drug Discovery Market Size by Application (2023-2028)
      • 8.3.3 Asia-Pacific Phenotypic Drug Discovery Market Share by Application (2017-2028)
    • 8.4 Asia-Pacific Phenotypic Drug Discovery Market Size by Region
      • 8.4.1 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2017-2022)
      • 8.4.2 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2023-2028)
      • 8.4.3 China
      • 8.4.4 Japan
      • 8.4.5 South Korea
      • 8.4.6 Southeast Asia
      • 8.4.7 India
      • 8.4.8 Australia

    9 Latin America

    • 9.1 Latin America Phenotypic Drug Discovery Market Size (2017-2028)
    • 9.2 Latin America Phenotypic Drug Discovery Market Size by Type
      • 9.2.1 Latin America Phenotypic Drug Discovery Market Size by Type (2017-2022)
      • 9.2.2 Latin America Phenotypic Drug Discovery Market Size by Type (2023-2028)
      • 9.2.3 Latin America Phenotypic Drug Discovery Market Share by Type (2017-2028)
    • 9.3 Latin America Phenotypic Drug Discovery Market Size by Application
      • 9.3.1 Latin America Phenotypic Drug Discovery Market Size by Application (2017-2022)
      • 9.3.2 Latin America Phenotypic Drug Discovery Market Size by Application (2023-2028)
      • 9.3.3 Latin America Phenotypic Drug Discovery Market Share by Application (2017-2028)
    • 9.4 Latin America Phenotypic Drug Discovery Market Size by Country
      • 9.4.1 Latin America Phenotypic Drug Discovery Market Size by Country (2017-2022)
      • 9.4.2 Latin America Phenotypic Drug Discovery Market Size by Country (2023-2028)
      • 9.4.3 Mexico
      • 9.4.4 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Phenotypic Drug Discovery Market Size (2017-2028)
    • 10.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Type
      • 10.2.1 Middle East & Africa Phenotypic Drug Discovery Market Size by Type (2017-2022)
      • 10.2.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Type (2023-2028)
      • 10.2.3 Middle East & Africa Phenotypic Drug Discovery Market Share by Type (2017-2028)
    • 10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Application
      • 10.3.1 Middle East & Africa Phenotypic Drug Discovery Market Size by Application (2017-2022)
      • 10.3.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Application (2023-2028)
      • 10.3.3 Middle East & Africa Phenotypic Drug Discovery Market Share by Application (2017-2028)
    • 10.4 Middle East & Africa Phenotypic Drug Discovery Market Size by Country
      • 10.4.1 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2017-2022)
      • 10.4.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2023-2028)
      • 10.4.3 Turkey
      • 10.4.4 Saudi Arabia
      • 10.4.5 UAE

    11 Key Players Profiles

    • 11.1 Eurofins Discovery
      • 11.1.1 Eurofins Discovery Company Details
      • 11.1.2 Eurofins Discovery Business Overview
      • 11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction
      • 11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.1.5 Eurofins Discovery Recent Developments
    • 11.2 Sygnature Discovery
      • 11.2.1 Sygnature Discovery Company Details
      • 11.2.2 Sygnature Discovery Business Overview
      • 11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction
      • 11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.2.5 Sygnature Discovery Recent Developments
    • 11.3 PsychoGenics
      • 11.3.1 PsychoGenics Company Details
      • 11.3.2 PsychoGenics Business Overview
      • 11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction
      • 11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.3.5 PsychoGenics Recent Developments
    • 11.4 siTOOLs Biotech
      • 11.4.1 siTOOLs Biotech Company Details
      • 11.4.2 siTOOLs Biotech Business Overview
      • 11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction
      • 11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.4.5 siTOOLs Biotech Recent Developments
    • 11.5 PhoreMost
      • 11.5.1 PhoreMost Company Details
      • 11.5.2 PhoreMost Business Overview
      • 11.5.3 PhoreMost Phenotypic Drug Discovery Introduction
      • 11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.5.5 PhoreMost Recent Developments
    • 11.6 Charles River
      • 11.6.1 Charles River Company Details
      • 11.6.2 Charles River Business Overview
      • 11.6.3 Charles River Phenotypic Drug Discovery Introduction
      • 11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.6.5 Charles River Recent Developments
    • 11.7 MaxWell
      • 11.7.1 MaxWell Company Details
      • 11.7.2 MaxWell Business Overview
      • 11.7.3 MaxWell Phenotypic Drug Discovery Introduction
      • 11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.7.5 MaxWell Recent Developments
    • 11.8 Arctoris
      • 11.8.1 Arctoris Company Details
      • 11.8.2 Arctoris Business Overview
      • 11.8.3 Arctoris Phenotypic Drug Discovery Introduction
      • 11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2017-2022)
      • 11.8.5 Arctoris Recent Developments

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Author Details

      Summary:

      Market Analysis and Insights: Global Phenotypic Drug Discovery Market
      The global Phenotypic Drug Discovery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
      Fully considering the economic change by this health crisis, Platform accounting for % of the Phenotypic Drug Discovery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Cancer segment is altered to an % CAGR throughout this forecast period.
      China Phenotypic Drug Discovery market size is valued at US$ million in 2021, while the North America and Europe Phenotypic Drug Discovery are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Phenotypic Drug Discovery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Phenotypic Drug Discovery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Phenotypic Drug Discovery market in terms of revenue.
      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Phenotypic Drug Discovery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Phenotypic Drug Discovery market.
      Impact of Covid-19 Outbreak
      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
      Segmental Analysis
      The report has been segmented into product and application segments. The researchers have documented all the products present today in the Phenotypic Drug Discovery market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
      Phenotypic Drug Discovery Breakdown Data by Type
      Platform
      Service
      Phenotypic Drug Discovery Breakdown Data by Application
      Cancer
      Viral Infection
      Genetic Disease
      Others
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Nordic Countries
      Rest of Europe
      Asia-Pacific
      China
      Japan
      South Korea
      Southeast Asia
      India
      Australia
      Rest of Asia
      Latin America
      Mexico
      Brazil
      Rest of Latin America
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of MEA
      Competitive Landscape
      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
      Eurofins Discovery
      Sygnature Discovery
      PsychoGenics
      siTOOLs Biotech
      PhoreMost
      Charles River
      MaxWell
      Arctoris
      Frequently Asked Questions
      What factors will challenge the Phenotypic Drug Discovery market growth?
      Which end-use segment will expand at the fastest CAGR in the Phenotypic Drug Discovery market?
      Which are the emerging players in the Phenotypic Drug Discovery market?
      How concentrated is the Phenotypic Drug Discovery market?
      Which factors are positively contributing to the Phenotypic Drug Discovery market growth?
      Which are the novel product innovations in the Phenotypic Drug Discovery market?
      Which product segment will emerge as the most lucrative in the Phenotypic Drug Discovery market?
      Which factors are increasing the competition in the Phenotypic Drug Discovery market?
      Which are the strategic measures taken by the Phenotypic Drug Discovery industry players?
      Which region will witness inactive growth during the forecast period?
      What key trends are likely to emerge in the Phenotypic Drug Discovery market in the coming years?
      Buy now